Romagnani P, Agarwal R, Chan J, Levin A, Kalyesubula R, Karam S
Nat Rev Dis Primers. 2025; 11(1):8.
PMID: 39885176
DOI: 10.1038/s41572-024-00589-9.
Dong Z, Wang X, Pan S, Weng T, Chen X, Jiang S
NPJ Digit Med. 2025; 8(1):50.
PMID: 39856403
PMC: 11759696.
DOI: 10.1038/s41746-024-01393-1.
Son H
Electrolyte Blood Press. 2025; 22(2):29-32.
PMID: 39780851
PMC: 11704316.
DOI: 10.5049/EBP.2024.22.2.29.
DallEra M, Kalunian K, Solomons N, Truman M, Hodge L, Yap E
Lupus Sci Med. 2024; 11(2).
PMID: 39521453
PMC: 11552023.
DOI: 10.1136/lupus-2024-001319.
Amioka M, Kinoshita H, Fuji Y, Nitta K, Yamane K, Shokawa T
ESC Heart Fail. 2024; 12(1):447-455.
PMID: 39340221
PMC: 11769660.
DOI: 10.1002/ehf2.15088.
Lupus nephritis-related chronic kidney disease.
Lichtnekert J, Anders H
Nat Rev Rheumatol. 2024; 20(11):699-711.
PMID: 39317803
DOI: 10.1038/s41584-024-01158-w.
The Renoprotective Mechanisms of Sodium-Glucose Cotransporter-2 Inhibitors (SGLT2i)-A Narrative Review.
Iordan L, Gaita L, Timar R, Avram V, Sturza A, Timar B
Int J Mol Sci. 2024; 25(13).
PMID: 39000165
PMC: 11241663.
DOI: 10.3390/ijms25137057.
Randomized Trial of SGLT2 Inhibitor Identifies Target Proteins in Diabetic Kidney Disease.
Ahluwalia T, Ronkko T, Eickhoff M, Curovic V, Siwy J, Eder S
Kidney Int Rep. 2024; 9(2):334-346.
PMID: 38344728
PMC: 10851015.
DOI: 10.1016/j.ekir.2023.11.020.
Downregulating lncRNA MIAT attenuates apoptosis of podocytes exposed to high glucose.
Xia J, Huang Y, Ma M, Liu F, Cao B
Acta Diabetol. 2023; 61(4):451-460.
PMID: 38072843
DOI: 10.1007/s00592-023-02213-w.
Contrast Agent-Free 3D Renal Ultrafast Doppler Imaging Reveals Vascular Dysfunction in Acute and Diabetic Kidney Diseases.
Oh D, Lee D, Heo J, Kweon J, Yong U, Jang J
Adv Sci (Weinh). 2023; 10(36):e2303966.
PMID: 37847902
PMC: 10754092.
DOI: 10.1002/advs.202303966.
Role and mechanisms of SGLT-2 inhibitors in the treatment of diabetic kidney disease.
Dai Z, Chen J, Zou R, Liang X, Tang J, Yao C
Front Immunol. 2023; 14:1213473.
PMID: 37809091
PMC: 10552262.
DOI: 10.3389/fimmu.2023.1213473.
Gliflozins, Erythropoietin, and Erythrocytosis: Is It Renal Normoxia- or Hypoxia-Driven?.
Heyman S, Abassi Z
J Clin Med. 2023; 12(14).
PMID: 37510986
PMC: 10381125.
DOI: 10.3390/jcm12144871.
Impact of sodium-glucose co-transporter 2 inhibitors on renal outcomes in patients of diabetes mellitus: A meta-analysis of landmark renal and cardiovascular outcome trials.
Bose D, Maurya M, Konwar M
Indian J Pharmacol. 2023; 55(2):119-127.
PMID: 37313937
PMC: 10335648.
DOI: 10.4103/ijp.ijp_342_21.
Nephroprotective Properties of Antidiabetic Drugs.
Gerdes C, Muller N, Wolf G, Busch M
J Clin Med. 2023; 12(10).
PMID: 37240483
PMC: 10219007.
DOI: 10.3390/jcm12103377.
Pleiotropic Effects of Sodium-Glucose Cotransporter-2 Inhibitors in Cardiovascular Disease and Chronic Kidney Disease.
Rastogi A, Januzzi Jr J
J Clin Med. 2023; 12(8).
PMID: 37109162
PMC: 10143176.
DOI: 10.3390/jcm12082824.
SGLT2 Inhibitors in Diabetic and Non-Diabetic Chronic Kidney Disease.
Podesta M, Sabiu G, Galassi A, Ciceri P, Cozzolino M
Biomedicines. 2023; 11(2).
PMID: 36830815
PMC: 9953060.
DOI: 10.3390/biomedicines11020279.
Kidney Drug Transporters in Pharmacotherapy.
Lapczuk-Romanska J, Drozdzik M, Oswald S, Drozdzik M
Int J Mol Sci. 2023; 24(3).
PMID: 36769175
PMC: 9917665.
DOI: 10.3390/ijms24032856.
Analysis of the Renal Protection and Antioxidative Stress Effects of Panax notoginseng Saponins in Diabetic Nephropathy Mice.
Mi W, Yu M, Yin S, Ji Y, Shi T, Li N
J Immunol Res. 2022; 2022:3610935.
PMID: 36249425
PMC: 9556179.
DOI: 10.1155/2022/3610935.
Diabetic Proteinuria Revisited: Updated Physiologic Perspectives.
Heyman S, Raz I, Dwyer J, Weinberg Sibony R, Lewis J, Abassi Z
Cells. 2022; 11(18).
PMID: 36139492
PMC: 9496872.
DOI: 10.3390/cells11182917.
Acute and chronic kidney complications in children with type 1 diabetes mellitus.
Rivetti G, Hursh B, Del Giudice E, Marzuillo P
Pediatr Nephrol. 2022; 38(5):1449-1458.
PMID: 35896816
PMC: 10060299.
DOI: 10.1007/s00467-022-05689-w.
